Preoperative prediction of axillary lymph node burden in early-stage invasive breast cancer

Preoperative prediction of axillary lymph node burden in early-stage invasive breast cancer with clinical-pathology and MRI-based radiomics

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN37165899

Enrollment

200

Registered

2024-06-26

Start date

2023-05-01

Completion date

Unknown

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early stage breast cancer patients Cancer

Interventions

This study will retrospectively search a database to identify breast MRI images that meet specific inclusion and exclusion criteria. Owners of the selected breast MRI scans will be enrolled in the stu

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Invasive breast carcinoma confirmed by biopsy 2. Early-stage (clinical stage T1-2) 3. Underwent DCE-MRI examination one week before surgery 4. All patients who received axillary surgery either SLNB or ALND

Exclusion criteria

Exclusion criteria: 1. Non-primary breast cancer or carcinoma in situ-only lesions 2. Excision biopsy before DCE-MRI examination 3. Pre-operative neoadjuvant therapy 4. Incomplete clinical data

Design outcomes

Primary

Measure	Time frame
Axillary lymph node burden prediction measured using the model prediction and MRI pathology reports after the axillary surgery at one timepoint	—

Secondary

Measure	Time frame
Performance comparison measures using the prediction model and by a radiologist after the axillary surgery at one timepoint	—

Countries

Taiwan

Contacts

Public ContactShu Tian Chen

sugarcan99@cgmh.org.tw+886 053621000

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026